Loading data
FEMYNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.29 m USD | 1.63 m USD | 1.07 m USD | 1.21 m USD | 1.18 m USD |
| Cost of revenue | 872.4 k USD | 544.9 k USD | 380.07 k USD | 441.94 k USD | 370.38 k USD |
| Gross profit | — | — | — | 764.28 k USD | 809.31 k USD |
| Research and development expense | 7.58 m USD | 8.22 m USD | 7.21 m USD | 5.81 m USD | 4.08 m USD |
| Operating profit | -17.59 m USD | -17.79 m USD | -14.51 m USD | -11.6 m USD | -8.34 m USD |
| Interest expense | — | — | 165.39 k USD | 13.46 k USD | 19.23 k USD |
| Profit before tax | -18.63 m USD | -18.81 m USD | -14.24 m USD | -11.39 m USD | -7.53 m USD |
| Income tax expense | 1.3 k USD | 9.6 k USD | 4.34 k USD | 6.3 k USD | 4 k USD |
| Net income (reported basis) | -18.63 m USD | -18.82 m USD | -14.25 m USD | -11.39 m USD | -7.54 m USD |
| Net income attributable to common shareholders | -18.63 m USD | -18.82 m USD | -14.25 m USD | -11.39 m USD | -7.54 m USD |
| Basic earnings per share | -0.47 USD/share | -0.85 USD/share | -0.93 USD/share | -0.96 USD/share | -1.12 USD/share |
| Diluted earnings per share | -0.47 USD/share | -0.85 USD/share | -0.93 USD/share | -0.96 USD/share | -1.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.